{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T16:39:46Z","timestamp":1649003986584},"reference-count":8,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.3899\/jrheum.111577","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T11:35:09Z","timestamp":1338550509000},"page":"1297-1298","source":"Crossref","is-referenced-by-count":1,"title":["Miliary Tuberculosis Following Negative Latent Tuberculosis Infection Screening Prior to Tumor Necrosis Factor-\u03b1 Antagonists: Implications for Management?"],"prefix":"10.3899","volume":"39","author":[{"given":"BENJAMIN W.","family":"TEH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALAN C.","family":"STREET","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EMMA S.","family":"McBRYDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUSTIN T.","family":"DENHOLM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2012,6,1]]},"reference":[{"key":"2018112909275516000_39.6.1297.1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq242"},{"key":"2018112909275516000_39.6.1297.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei103"},{"key":"2018112909275516000_39.6.1297.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.118935"},{"key":"2018112909275516000_39.6.1297.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.21043"},{"key":"2018112909275516000_39.6.1297.5","unstructured":"Australian Rheumatology Association . Screening for latent tuberculosis infection (LTBI) prior to the use of biological agents in Australia. Therapeutics Committee, Australian Rheumatology Association. April 2010. [Internet. Accessed March 7, 2012.] Available from: http:\/\/tbevidence.org\/documents\/guidelines\/Australian%20TNF%20screening%202010.pdf"},{"key":"2018112909275516000_39.6.1297.6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5694\/j.1326-5377.2008.tb01565.x","article-title":"Tumour necrosis factor alpha inhibitors: Screening for tuberculosis infection in inflammatory bowel disease","volume":"188","author":"Gupta","year":"2008","journal-title":"Med J Aust"},{"key":"2018112909275516000_39.6.1297.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"2018112909275516000_39.6.1297.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090150"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.111577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T08:58:46Z","timestamp":1594198726000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.111577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":8,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,1]]},"published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.3899\/jrheum.111577"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.111577","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}